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Abstract
Purpose The aim of our paper was to validate a testicular
biopsy procedure that simplifies handling, processing, and
cryopreservation, while at the same time optimizes sperm mo-
tility before freezing and after thawing.
Methods Two prospective studies were conducted to verify,
optimize, and understand the virtues of pre-freeze testicular
tissue IVC at different temperatures (21, 30, or 37 °C).
Testicular tissue was obtained from clinical specimens desig-
nated for whole tissue cryopreservation (i.e., intact mass of
tubules) and/or for fresh use in IVF-ICSI cycles. Whole tes-
ticular biopsy pieces (1–3 mm3) were diluted in glycerol con-
taining freeze solutions, slow cooled to 4 °C and then rapidly
frozen in LN2 vapor. Fresh and post-thaw testicular biopsy
tissue were evaluated for changes in the quantity (%) and
pattern of motility (I–IV: twitching to rapid progression, re-
spectively) over a 1 week duration. The clinical effectiveness
of IVC-cryopreserved whole testicular biopsy tissue was also
validated analyzing fresh embryo transfers.
Results More reliable recovery of motile testicular sperm was
achieved using whole tissue freeze preservation combined
with IVC (24–96 h) post-acquisition at an incubation temper-
ature of 30 °C compared to ambient temperature (21 °C) or
37 °C. Up to 85 % of the pre-freeze motility was conserved
post-thaw (+3 h) for easy ICSI selection. Sperm longevity was
optimized to fresh tissue levels by implementing testicular
biopsy sucrose dilution post-thaw. Favorable clinical out-
comes were proven using frozen-thawed testicular biopsy
sperm for ICSI.
Conclusions By employing minimal tissue manipulation, in-
tegrating pre-freeze IVC processing at 30 °C and the freezing
of whole testicular biopsy tissue, we have reduced the labor
and improved the efficacy of processing testicular tissue for
freeze-preservation and subsequent ICSI use.
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Introduction
The use of human testicular sperm as a male infertility treat-
ment was enabled by the development of ICSI over 2 de-
cades ago [1–4]. However, the ability to process, evaluate,
and properly use surgically acquired testicular sperm in-
volves a steep and challenging learning curve [5–7].
Verheyen and coworkers [8] evaluated four different me-
chanical methods (control shredding, fine mincing,
vortexing, and crushing) to dissociate testicular sperm from
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seminiferous tubules. There was little difference in the
amount and quality of sperm dispersed by shredding or
mincing before Percoll density gradient separation.
However, more free sperm were isolated post-Percoll wash-
ing in the fine minced group, but not without a significant
loss in total recovery of sperm. Since the quantity of sperm
found in a testicular biopsy may be limited, fine needle or
glass slide shredding is a common mechanical method for
tissue dispersion used by embryologists [9]. Alternatively,
the compression squeezing of individual tubules with a bent,
smooth needle surface can be performed to push cellular
contents into the culture medium [10, 11]. Many urologists
however, have adopted the fine tissue mincing technique
that employs dissecting scissors to generate small tubular
segments and free spermatozoa in solution [8, 12, 13].
Independent of the method used for cellular dispersion,
a fundamental problem is the time and expertise needed to
sift through a three dimensional mix of testicular cells and
tissue to find sperm that is generally immotile. This is
complicated by the fact that the normal cellular
architecture of the testis (Fig. 1a) is absent in cell suspen-
sion preparations. Medical illustrations that identify indi-
vidual spermatogenic cell types (e.g., Atlas of Human
Spermatogenesis) have helped aid the learning process to
some degree, but has not lowered the overall expertise
levels needed for full laboratory proficiency in germ cell
identification.
Other issues can add to the complexity of identifying
sperm in testicular biopsy samples. Often, minced testicu-
lar biopsy tissue dispersions are contaminated with high
concentrations of red blood cells, making it more difficult
to characterize cells and observe free floating, non-motile
sperm. Erythrocyte lysing buffers are helpful in such cases
in isolating motile and non-motile sperm [14]. Yet, RBC
contamination can be minimized by generous irrigation
during surgery and rinsing tubules well before dispersion.
In cases of non-obstructive azoospermia where sperm
identification is extremely difficult, enzymatic digestion
of tissue has been applied to free sperm from tissue
masses, allowing up to 24 % additional detection of sperm
Fig. 1 In panel a, a tricolor-
stained histograph (×200
magnification; courtesy of Dr.
Charles Sims, M.D.) of thin-
sectioned testicular tissue exhibits
normal spermatogenesis, from
spermatogonia to sperm release in
the tubule lumen. Round cell
spermatid transition to sperm
formation is clearly evident (a).
The tissue mass is composed of
seminiferous tubules which can
be easily dissected into smaller
masses (b) for subsequent
evaluation or cryopreservation.
Using fine needles to shred the
tubules of a small testis mass (c)
in a droplet of medium under oil,
the dispersed cellular contents of
the tissue are allowed to settle and
equilibrate (d) before evaluation
under inverted microscopy (e,
hpf = ×400 magnification). This
panel depicts normal
spermatogenesis, as revealed by a
variable size cell population and
the presence of >5 sperm/hpf. A
styrofoam box containing tube
racks (f) is used as a testicular
biopsy incubator (when covered),
attaining an optimal temperature
of 30 °C to culture testicular
sperm, while resting on a 37 °C
slide warmer surface
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compared to non-digested preparations [15, 16]. The use
of a mortar and pestal to grind tissue has also been de-
scribed as a way to free sperm from host tissue [17].
Many strategies have been developed for identifying and
processing testicular sperm. However, little effort has been
made to implement practical measures that optimize cryo-
preservation outcomes, while reducing the labor demand on
technicians. Instead, most laboratories thoroughly process
and freeze testicular tissue on the same day of the testicular
biopsy, without regard to the additional processing and post-
thaw labor time that will be needed to find viable sperm for
subsequent ICSI use.
In our early experience with the cryopreservation of tes-
ticular sperm, we found an interesting difference in the post-
thaw viability of different morphological sperm types based
on vitality stains. Maturing sperm possessing a cellular rem-
nant encapsulating their head (i.e., late spermatid) preferen-
tially survived freezing with significantly higher vitality
(74 %) compared to free-floating normal (19 %) or abnormal
sperm (31 %, bent necks/midpieces with residual cytoplas-
mic droplets) unassociated with tissue [18]. Interestingly,
cryosurvival appeared to be associated with residual cellular
protection to the centrosome region. Thus, we justified the
adoption of whole tissue cryopreservation as a means to
optimize cellular co-survival of testicular spermatozoa
(Fig. 2). We learned that the in-vitro culturing (IVC) of
testicular biopsy tissue at ambient temperature over time
(+24 to +96 h) would typically enhance sperm motility
pre-freeze, which benefited post-thaw motility recovery.
Furthermore, under changing laboratory environmental con-
ditions (i.e., temperature), we noticed an improvement in
testicular biopsy sperm motility and longevity associated
with elevated temperatures from 21 to 27–30 °C (Fig. 2),
as was documented by others [19].
We have shown that ICSI of motile frozen-thawed tes-
ticular biopsy sperm yields comparable fertilization rates
to fresh controls using motile or non-motile sperm (Table
1). Whereas, frozen-thawed sperm which were not dis-
tinctly motile produced fewer (p< 0.05; Table 1) 2PN zy-
gotes, unless sperm encapsulated in a cellular remnant
were preferentially selected. Resulting embryos by sperm
type (fresh or frozen) exhibited no difference in pregnan-
cy outcomes (Table 1). Overall, similar live births oc-
curred using fresh (47 %) or frozen-thawed testicular bi-
opsy sperm (50 %), which is in agreement with other
reports [9, 20, 21].
Given these issues and the fact that testicular sperm retriev-
al procedures are more popular than ever [22, 23], it is sur-
prising that after 20 years of practice, laboratories still struggle
to find testicular tissue preparation regimens that minimize
labor and effort, while optimizing sperm isolation for ICSI.
The aim of this paper was to highlight the evolution of an
effective, practical laboratory approach to testicular biopsy
handling and processing which not only improves pre-freeze
Testicular tissue IVC at room temperature
1995-99 until ICSI procedure (typically 18-24 h)
Developmental Cryopreservation of whole biopsy tubules 
Clinical Phase (1:1 dilution in 15% glycerol based solution)
2000-03 IVC under elevated ambient temperature (27-30 C)
IVC under controlled conditions at 30 C
2004 Whole tissue cryopreservation upon attaining
Validation - (Study 1) progressive sperm motility at +24 to 96h using a
Verification 20% glycerol solution (1:1 dilution); 
Experiments Direct post-thaw dilution in H-HTF medium.
2007 Comparative IVC at C, 30 C C;
(Study 2) Whole tissue cryopreservation using a commercial 
26.7% glycerol solution (1:1 dilution);
Sucrose dilution post-thaw to more effectively
remove residual glycerol from tissue pre-shredding
Clinical Application 2007- Date Optimization of pre-freeze and post-thaw sperm 
motility using 30 C IVC / whole tissue freezing
Fig. 2 Experimental design schematic reveals the developmental phase
of adopting whole testicular tissue cryopreservation and observing
improvements in IVC motility characteristics associated with a change
of laboratory environments/elevated ambient temperatures. In 2004, a
verification study (study 1) was conducted to evaluate the beneficial
effect of controlling the IVC temperature at 30 °C with daily repeated
measures of motility overtime (1 week) pre-freeze and post-thaw.
Subsequently, in 2007, a prospective apriori study of three different tem-
perature treatments (21, 30, 37 °C) with repeated measures of motility
was performed to validate the optimum effect of an intermediate temper-
ature on the promotion of progressive sperm motility of longevity.
Furthermore, due to the suspected negative effect of residual glycerol in
post-thawed testicular tissue sperm longevity in study 1, all freeze-thawed
testicular tissue in study 2 was exposed to a 0.5 M sucrose solution prior
to dilution in H-HTF medium. In addition, the progressive use of higher
glycerol solution concentrations was to insure effective permeation of
cryoprotectant into tissue, as well as adopting a practical commercial
product (shifting from a 20 % glycerol to 26.7 % glycerol solution in
study 1 and 2, respectively). Finally, no randomization was performed as
all repeated measures (study 1 and 2) and IVC treatments were equally
applied to each patient specimen. The applications of our optimized min-
imal manipulation treatments (i.e., whole tissue IVC/cryopreservation)
over the past 7 years have validated and verified its clinical effectiveness
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and post-thawmotility, but alsominimizes the procedural time
and efforts needed to optimize IVF laboratory application.
Materials and methods
Evaluation of testicular biopsy tissue in the operating
room
Human testicular biopsy tissue was acquired from both non-
obstructive azoospermic (NOA) and obstructive azoospermic
(OA) patients via open surgical procedures [5, 24, 25].
Seminiferous tubular masses (i.e., testicular biopsy) were ex-
cised and placed into a small petri dish (35 mm; Fig. 1b)
containing 3 ml HTF medium with HEPES buffer and 5 %
HSA (H-HTF+; Irvine Scientific, Santa Ana, CA). By gross
examination, testicular biopsies were then manipulated with
sterile needles (19–28 ga) attached to 1 cc tuberculin syringes
to coarsely dissect tissue. A small tissue sample (1–
3 mm3) was teased away from the whole testicular biopsy
(Fig. 1b) and placed into 1 of 4 100–150 μl droplets of H-
HTF+ medium in a large Falcon petri dish (100 mm×15 mm;
Fig. 1d) for preliminary evaluation. Each droplet was flattened
and covered with 17 ml of light mineral oil. While under oil, the
representative tissue sample was shredded between the two
needles (Fig. 1c) to release the cellular contents and enable sper-
matozoa identification using an inverted microscope (×400
magnification). If the presence of spermwas confirmed, surgical
procedures were terminated; otherwise, additional testicular tis-
sue was systematically sampled from one or both testicles.
Typically, if the identification of more than a single sperm was
not achieved within 10 min, multiple biopsies were taken to
fully assess them later in the ART Lab. Testicular biopsy con-
taining petri dishes was placed into a covered 30×20×20cm
styrofoam box (3 cm wall thickness; Fig. 1f) and returned to the
laboratory for further evaluation and processing.
Testicular biopsy processing and assessment
Detailed processing and further evaluation of the testicular
biopsy was continued in the laboratory in two stages: (1) com-
plete processing and assessment of the initial representative
sample (Fig. 1b, e) and (2) separation of whole testicular bi-
opsy pieces for subsequent cryopreservation (Fig. 1b). Using
stereomicroscopy, the representative testicular biopsy sample
initially assessed in the OR (classified as a Bfresh TEST
sample^) was more thoroughly dissected between needles to
achieve complete cellular dispersion (Fig. 1c, e) and the resid-
ual tissue moved to an unused H-HTF+ droplet under oil. The
latter large dish was then placed on a 37 °C surface before
reevaluating the TEST sample 1–3 h later. While equilibrating
the shredded testicular biopsy TEST sample, the primary tes-
ticular biopsy mass(es) were subdivided by needle dissection
(Fig. 1b) into a minimum of six testicular biopsy pieces (4+
whole testicular biopsy pieces for cryopreservation, a small
TEST whole testicular biopsy freeze sample; as well as the
initial fresh shredded TEST sample; Fig. 1d, e). The separate
whole testicular biopsy pieces (1–3 mm3) were aseptically
handled and placed into labeled, sterile individual cryovials
containing 0.25 ml H-HTF+ and maintained in the warmed
styrofoam box/racks for IVC (Fig. 1f) until the time point at
which progressive motility was confirmed in the pre-freeze
fresh TEST sample (typically 48–72 h). Sperm longevity
was evaluated daily for up to 1 week (+168 h post-testicular
biopsy). Testicular tissue was maintained under varying am-
bient conditions prior to 2004. Beginning in 2004, all IVCwas
controlled at 30±1 °C in the styrofoam box maintained on a
37 °C surface, as defined previously.
Table 1 Clinical outcomes of
IVF/ICSI cases using testicular
biopsy sperm at the CFA and
SIFT clinics between 1996 and
1999
TBx sperm # Pts # Eggs ICSI # 2PN (%) # CP (%) # LB (%) # Babies Born
Fresh 15 164 115 (70) 7 [47] 7 [47] 11
Non-motile spermb [6] 56 37 (66) 3 (50) 3 (50) 4
Type ≥II sperm [9] 108 78 (72) 4 [44] 4 [44] 7d
Frozen-thawed 10 120 67 (56) 6 (60) 5 (50) 8
Non-motile spermb c 26 7 [27]a 1 (100) 1 (100) 1
Non-motile L.Sptd [4] 26 15 (58) 2 (67) 2 (67) 3
Type ≥II sperm [6] 66 45 (68) 3 (50) 2 [33] 4
IVF/ICSI cases excluding women ≥38 years old, CP clinical pregnancies, LB Live births
a Column values are different (p < 0.05) than all other values
bMicropipette Btouch-test^ as applied to select potentially viable spermatozoa
c Eggs were split evenly between sperm types in this patient group who had few, if any, twitching sperm by a
Btouch-response^ test. The remaining sperm injected were non-motile, including the 50% sperm encapsulated in
cellular reminant, i.e., late spermatid (L Sptd) group
dA set of triplets was conceived using motile sperm +96 h post-TBx (1996)
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The dispersed cellular contents of the testis tissue were
subjectively assessed using high power field (hpf; 400×) de-
terminations. The following criteria were used to grade the
quantity of sperm found: normal =>5 sperm/hpf (Fig. 1f),
moderate = 3–5 sperm/hpf, fair = 1–2 sperm/hpf, and
low=<1/hpf. Very low sperm yields characteristic of difficult
NOA cases was further defined as 1 sperm/number of hpf’s or
perhaps as the total number of sperm found in the sample.
Within 3 h post-receipt of testis tissue (time 0), a baseline
examination of specimen quality was performed. In addition
to an assessment of sperm quantity as described above, total
percent motility was evaluated on at least 100 sperm. Sperm
motility was assessed by a classification index: type:
I = twitching, II = non-progressive, undulating flagellar mo-
tion, III = slow progressive motion, and IV= rapid movement.
Motility was assessed daily in TEST samples of incubated
testicular biopsy specimens.
Experimental design
Our development and optimization of whole testicular biopsy
IVC and cryopreservation evolved over time (Fig. 2), with
prospective verification and validation studies being initiated
in 2004. Although the developmental phases and experiments
were performed at several facilities, all lab procedures and
evaluations were conducted by a single embryologist
(MCS). Duplicate evaluations were performed with the assis-
tance of various lab staff members. In study 1, we evaluated
the use of a controlled temperature (30 °C) for testicular
biopsy-IVC (n=12 OA men). The aim was to verify the ef-
fectiveness of testicular tissue IVC on the sperm motility of
fresh and frozen-thawed specimens at 24 h intervals over a
1 week duration and to assess differences in survivability. The
extended analysis was performed in conjunction with the stan-
dard assessment of TEST samples from patients consenting to
whole testicular biopsy cryopreservation.
A secondary prospective, controlled validation study was
conducted (n=10 OA men; study 2) in conjunction to an IRB
approved stem cell study [26]. Consenting patients approved
the use of residual testicular biopsy tissue for experimental
purposes. Each testicular biopsy was dissected into eight equal
pieces. Five intact pieces of testicular biopsy were cryopre-
served in separate cryovials for future use. Patient testicular
biopsy tissue for cryopreservation was handled, maintained
(30 °C), and processed using standard whole testicular biopsy
cryopreservation procedures (as described below). The remain-
ing testicular biopsy tissue was subdivided into one of three
temperature treatment groups for each patient: room/ambient
temperature (RT; 21 °C); body temperature (37 °C), or 30 °C
for extended IVC. Fresh TEST tissue dishes from each patient
were prepared for each different temperature condition.
Comparative assessments of motility quality (type I–IV) and
quantity (%) were recorded at +24, +96, and +168 h of IVC
under treatment conditions. In addition, all frozen TEST sam-
ples from study 2 patients were prospectively thawed and eluted
in 0.5 M sucrose solution (study 2b), as described below, in an
attempt to extend sperm longevity similar to fresh tissue. Each
sample was assessed daily for up to 1 week, similar to study 1.
The clinical effectiveness of IVC at an intermediate tem-
perature of 30 °C was assessed in study 1 and study 2 for
women ≤42 years old. Statistical analyses involved the use
of a chi-squared test to assess differences (p<0.05) in the
proportion (%) of sperm viability, total motility/day, normal
fertilization, clinical pregnancy, and live birth rates between
treatment groups. Furthermore, treatment differences in total
and progressive motility, within and between intervals (Figs. 3
and 4), were contrast by chi squared analysis.
Testicular cryopreservation and thawing
The whole testicular biopsy tissue pieces (approximately
2×2×1 mm3) were cryopreserved after 30 °C IVC of 24 to
+96 h post-biopsy, depending on the confirmation of type III
and IV motile sperm being detected. Testis tissue was frozen
in a 20 % glycerol solution (v/v) in H-HTF medium +10 %
HSA that was prepared and filtered (0.22 μm) in-lab for use
(2000–2007; study 1 period); or in Sperm Maintenance
Medium (26.7 % glycerol, HSA-based; Irvine Scientific) after
2007 (study 2 period). Using a 5-step addition (1:1 dilution)
technique over 5 to 7 min, 50 μl of freeze mediumwas pipette
and mixed per 1–1.5 min/vial. Vials were then placed onto a
labeled cane for cooling and cryostorage. A 10 to 13.4 %
glycerol solution (0.5 ml final volume) was allowed to perme-
ate the tissue for 3–18 h under refrigerated conditions (5 °C)
depending on whether they were processed in the morning or
afternoon, respectively. The canes were then frozen directly in
LN2 vapor for 30 min prior to storage in LN2. Note, the freez-
ing procedure was developed to be practical and effective,
with no attempt being made to control the refrigeration inter-
val or contrast changes in glycerol content.
Tissue vials were thawed initially by slow warming and
equilibration at ambient temperature for 1 min. Upon
outgassing of LN2 vapors, vials were then rapidly warmed in
a 37 °C water bath for 5 min. Vial contents (i.e., whole tissue)
were then either evacuated into a 4-well dish to which an equal
volume of H-HTF+ medium was added (prior to 2007; study
1), or placed directly into a 0.5 M sucrose solution (1.78 g/
warm 10 ml H-HTF; filter sterilized) at room temperature to
more completely elute residual glycerol from the tissue
(≥2007; study 2). With either approach, after 5 min, the tes-
ticular biopsy tissue masses were rehydrated in and rinsed
twice in fresh H-HTF+ for 5 min intervals using sterile needles
for handling at ambient temperature to decrease residual ex-
tracellular glycerol. The equilibrated tissue was then moved to
fresh H-HTF+ droplets under oil, shred by needles and the
cellular contents allowed to warm at 37 °C for 1–3 h. Upon
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equilibration, post-thaw assessment of motility was performed
and re-evaluated daily for up to 1 week, under previously de-
scribed IVC incubation conditions (30±1 °C). TEST thaw re-
sults dictated whether testicular biopsy samples were thawed on
the morning, or 24 h in advance, of an ICSI procedure [27].
Results
Study 1
Upon dilution equilibration of dispersed testicular tissue for
3 h in HTF+ at 37 °C sperm began exhibiting motility (32 %
total), which was primarily non-progressive (24 %; Fig. 3a).
However, by 24 h IVC, there was a significant rise in total
motility (50 %) and progressive motility (8 to 15.7 %), which
increased (p<0.05) further at 72 to 96 h (24.3 and 29.5 %,
respectively). A maximum average total motility of 71 % was
attained at +96 h post-testicular biopsy, with a significant de-
cline in total motility observed at +120 h, but not in progres-
sive motility (23.3 %). Testicular sperm motility continued to
decrease (p<0.05) to 24 % total motility at +168 h, yet pro-
gressivemotility (14%) remained elevated to the +24 h levels.
Having typically cryopreserved the whole testicular biopsy
masses at +48 h of IVC, the average pre-freeze total motility
was 58 %, of which 20.2 % were considered progressive and
15 % undulating (Fig. 3b). The stress of cryopreservation
reduced (p<0.05) the initial post-thaw motility to 30 %, with
4.3 % being notably motile (undulating to progressive) sperm
for ICSI selection. An 85 % overall recovery of viable testic-
ular sperm was achieved by whole testicular biopsy tissue
cryopreservation based on the increased total and grade II–
IV motility at +24 h (49 and 18 %, respectively). The viability
of these sperm significantly declined at a much faster rate than
fresh tissue, reaching near zero levels at +120 h IVC (Fig. 3b).
In this study group of 12 ICSI cycles, 141 of 203 oocytes
fertilized (69.5 % 2PN) with no difference observed using
fresh IVC or thawed motile testicular sperm. In this mixed
age group (24 to 42 years, mean=35.4±5.3 years), 6 of 12
patients initiated pregnancy. The five live births (41.7 %) pro-
duced one set of triplets and three twins, resulting in a 23.2 %
implantation rate.
Study 2
Testicular sperm motility ranged from 5 to 25 % initially (1–
3 h post-testicular biopsy; primarily twitching) and increased
(p<0.05) in all groups at 24 h (Fig. 4). There was no differ-
ence (p>0.10) in total motility at 24 h (42 to 53.4 %), but
progressive motility was higher (p<0.05) at 30 and 37 °C
(12.7 and 11 %, respectively) compared to 21 °C (7.7 %).
Significant differences (p<0.05) were observed in total %
motility/% progressive motility, respectively, at 96 h with
treatment differences (*p < 0.05) being 30 °C (66 %*/
44 %*)>21 °C (42 %*/14 %)>37 °C (18 %*/10 %). This
statistical trend continued at 144 h with 30 °C (42 %*/
23 %*)>21 °C (24 %*/8 %)>37 °C (9 %*/5 %). Thus, the
optimization of progressive sperm motility and longevity sig-
nificantly favored the 30 °C IVC treatment.
As in study 1, when patient samples were thawed after being
cryopreserved at +48–72 h of 30 °C IVC, overt post-thaw
motility was observed (30–40 %). Nearly 15–20 % of the
thawed testicular sperm exhibited undulating to slow progres-
sive motility (type II–III) after 3 h equilibration at 37 °C. Upon
24 h IVC at 30 °C, total and progressive motility significantly
increased to 60 and 25 %, respectively, and then slowly de-
clined to 25 and 15 %, respectively, by 1 week post-thaw.
The sucrose eluted testicular biopsy tissue displayed a viability
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Fig. 3 The effects of extended IVC (30 °C) on the motility of testicular
sperm are graphically shown in stacked columnsmeasuringmotility types
(I to IV, twitching to rapid progression, respectively; a). In panel b, post-
thaw motility patterns of cryopreserved testicular biopsy sperm over time
(IVC at 30 °C) are shown in stacked columns measuring the four types of
motility. The total motility for each interval, in both panels, is indicated
within the lower sub-column. Good post-thaw survival was recovered for
cryopreserved whole testicular biopsy specimens in an actively motile
state. Upon equilibration, the optimal viability of the post-thaw samples
was acquired by +24 h IVC, which significantly declined at +48 and
+72 h in study 1 where residual glycerol had a toxic effect on longevity.
In each panel, subscript(s) atop each column denote significant differ-
ences between intervals
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During this study, a viable pregnancy was achieved using a
30 °C sample 8 days post-biopsy, exceeding two previous
healthy triplet pregnancies which were successful using
+96 h IVC testicular biopsy specimens in 1996 and 2005. In
review of 100 clinical cases performed at the SCIRS Lab,
between 2011 and 2014, the routine clinical use of IVC/
frozen-thawed testicular sperm has resulted in reliable, excel-
lent clinical outcomes (Table 2) and low miscarriage results,
comparable to those routinely attained with fresh ejaculated
sperm.
Discussion
Over the past 2 decades, we have learned that the management
of testicular biopsy/ICSI cycles does not have to be compli-
cated. A practical solution rests in adopting a simple and ef-
fective testicular biopsy tissue processing procedure, which
incorporates pre-freeze IVC motility enhancement and whole
tissue cryopreservation. Fresh testicular biopsy samples incu-
bated at 30 °C can maintain progressive motility for up to
1 week or more, and their viability can be efficiently cryopre-
served as intact tissue masses. We know that testicular sperm
are typically non-motile upon initial testicular biopsy analysis,
and that within 3 h of IVC warming, many sperm begin to
exhibit intermittent twitching or persistent undulating flagellar
movement. Overtime, IVC of testicular sperm can optimize
and extend progressive spermmotility. However, prolonged in
vitro incubation under suboptimal conditions can reduce
sperm motility and longevity, thus decreasing the efficacy of
testicular biopsy tissue for cryopreservation and subsequent
ICSI use. Our investigations and experience sought to address
these issues.
The low overall vitality of the stained frozen-thawed tes-
ticular biopsy sperm we observed in preliminary investiga-
tions in 1996 (30 %) was similar to other reports [13, 28]
and correlated to ICSI outcomes when randomly selecting
non-motile frozen-thawed sperm (27 % normal fertilization,
Table 1). Furthermore, we discovered that the cellular encap-
sulation of the sperm head/midpiece allowed the cytoplasm to
insulate the centrosome from cryodamage, preserving its func-
tionality. These early observations revealed a near 4-fold in-
crease in the vitality of cellular protected testicular sperm
compared to normal free-floating sperm, as well as a 2-fold
increase in normal fertilization when injecting non-motile
cells using a Btouch^ technique (Schiewe, unpublished data).
Interestingly, the subsequent success with IVC in study 1
determined that up to 70 % of the sperm freeze preserved as
intact tubules actually sustained their viability post-thaw,
based on observed post-thaw motility potential at +96 h
IVC. Thus, we revealed a discrepancy with our estimated
30 % vitality assessed at 0 h post-thaw in preliminary inves-
tigations. The early efforts of Crabbé and coworkers [13] fa-
vored frozen minced tissue suspensions (9.2 % motile and
39.3 % viable) compared to whole testicular biopsy cryo-
preservation (4 % motile and 25.4 % viable). Their
Table 2 Clinical outcomes of ICSI cases using IVC/frozen-thawed
whole testicular biopsy sperm at the SCIRS laboratory between 2011
and 2014
Mean female patient age 35.7 ± 4.8 SD
# of oocyte retrievals 100
# of mature oocytes injected 1356
# of 2 pronuclear zygotes 920 (67.9 %)
Total # fertilized 1023 (75 %)
# of embryo transfers-fresh embryos 60
# of positive pregnancies 35 (58.3 %)
# of clinical pregnancies 32 (53.3 %)
# of live birth outcomes 28 (47 %)
Fig. 4 In study 2, the effect of extended IVC on the motility of testicular
sperm was tested at three different incubation temperatures (21, 30, and
37 °C). The four types of motility (graded: I–IV) are graphically shown in
stacked columns measuring the total motility at each of four intervals.
Differences (p < 0.05) within each column between treatments are
reflected by subscript differences adjoining the total motility value.
Significant changes in motility patterns between intervals within
incubation treatments are indicated by the inclusion of a directional arrow
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findings did not seem to support our belief that the
centrosomes of normal immature sperm embedded with-
in tissue are more likely insulated from cryodamage.
However, we believe their observed differences in
motility/viability were due to an experimental flaw,
which did not account for the need to use higher glyc-
erol levels to effectively permeate the whole testicular
biopsy tissue pre-freeze. We have proven that whole
testicular biopsy cryopreservation is a simple and highly
effective approach to processing testicular biopsies.
Although we did not comparatively investigate testicular
biopsy cryopreservation procedures per se, we did show
that testicular biopsy exposure to sucrose post-thaw ef-
fectively removed residual glycerol from tissue to ex-
tend post-thaw sperm longevity, as opposed to the poor
extended survival seen in study 1 (Fig. 3B) with HTF+
diluted tissue. Clearly, if we are to further optimize
future freeze preservation efforts for testicular sperm/
biopsy tissue, there is a justified need to evaluate dif-
ferent cryo-additives, -protectants and procedures.
The basic standards for sperm cryopreservation have
been well established [29]. They typically involve
dropwise dilution of a glycerol-based cryoprotective so-
lution over a 7 to 15 min interval at room temperature
to reduce osmotic stress, yielding a 6 to 12 % glycerol
solution [10, 16, 19, 29–32]. The use of egg yolk as a
membrane stabilizer/protectant has been commonly re-
placed by human serum albumin in commercial freeze
formulations. Although the primary reason for this
change in the human IVF industry was the elimination
of animal origin products for clinical use, it has the
added benefit in freeze-thawed testicular biopsy tissue
of reducing excessive BBrowning movements.^ In the
early years of testicular biopsy freezing (1996–2000),
the rupturing of cytoplasmic contents in the shredding
of testicular biopsy tissue into a lipoprotein rich culture
medium yielded excess kinetic energy (i.e., random
movements), which complicated the ability to identify
barely twitching sperm for ICSI. In turn, our whole
testicular biopsy cryopreservation program evolved in
the late 1990s, focusing on improving pre-freeze motil-
ity to attain more undulating to progressive motile
sperm immediately post-thaw, as well as eliminating
egg yolk from our freeze media.
Freshly biopsied testicular biopsy tissue has relatively low
levels of undulating or progressively motile sperm within the
first 3 h post-testicular biopsy. Therefore, it is not surprising
that standard freezing of fresh testicular biopsy suspensions
typically results in little to no sperm motility. Liu and co-
workers [9] showed that the secondary culturing of testicular
biopsy sperm post-thaw for ≥72 h significantly improved pro-
gressive motility from 2 to 21 %. Over the years, many pro-
grams have adopted the thawing of testicular biopsy sperm
into standard practice +24 h prior to ICSI use [17, 33].
However, patient variation to the post-thaw recovery of mo-
tility varies and may show little to no improvement [9]. A
hypo-osmotic swelling test (HOST) [34, 35] and the chemical
addition of pentoxyfylline [36] have been used to help assess
the viability or stimulate the onset of motility of testicular
sperm, with the chemical treatment proving to be more reli-
able than HOST [37]. In addition, a mechanical touch tech-
nique has frequently been used to potentially judge the post-
thaw viability of immotile testicular sperm [20]. In all these
unfavorable post-thaw testicular sperm cases, embryologists’
are faced with implementing laborious, time-consuming or
chemically mediated measures to search, isolate, and use po-
tentially viable sperm for ICSI. Conversely, the simple use of
motile sperm immediately post-thaw (≤3 h) will always be the
preferred optimal alternative.
Our experience dictates that the more motile the tes-
ticular biopsy sperm, the better the post-thaw viability.
Reliable post-thaw motility facilitates the simple and
accurate selection/ isolation of viable testicular sperm
for ICSI. Under static IVC conditions at 30 °C, testic-
ular biopsy sperm acquired motility which progressively
increased in the first 96 h, similar to others showing
peak motility between 48 and 72 h at 32 to 37 °C
IVC [9, 19, 38]. As in our study, motility significantly
declines by +96 h when incubated at 37 °C. In addition,
the use of motile frozen-thawed testicular biopsy sperm
in our studies has produced comparable fertilization
rates to other reports [31, 39], but in contrast to Aoki
et al. [39], no difference in pregnancy/live birth out-
comes has been seen when contrasted to fresh testicular
biopsy sperm. It should be noted that while total motil-
ity begins declining after +96 h of 30 °C IVC, a pro-
portional increase in progressive motility was seen for
up to 1 week in fresh testicular biopsy tissue, as well as
post-thaw specimens when sucrose elution was applied
upon warming.
Clearly, the static IVC of testicular biopsy is not an
optimal system in contrast to promising potential devel-
opments with microfluidic culture systems [40, 41]. One
concern with extended static IVC, as well as testicular
biopsy freezing, has been a proposed increase in reac-
tive oxygen species (ROS) in solution, which could
damage the DNA integrity of testicular biopsy sperm.
Dalzell and coworkers [42] exhibited that the short in-
cubation (+4 h) of fresh testicular sperm increased the
DNA fragmentation index (DFI) from 11 to 22.1 %,
while frozen-thawed testicular sperm experienced higher
levels of change (17 to 30 %) without any further
changes at +24 h (fresh or frozen). Furthermore, it
was shown that slow frozen-rapid thawed testicular
sperm experienced cryodamage associated with DNA
fragmentation [43]. However, these studies failed to
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differentiate between live and dead sperm, which would
explain the lack of change in DFI of fresh samples at
≥24 h IVC. Whereas our proven success with both IVC
and testicular biopsy cryopreservation indirectly suggest
that elevated ROS and DFI observations are non-
detrimental factors, which likely are associated with
non-viable sperm. It has been proposed that the use of
sperm possessing elevated DFI levels for assisted repro-
ductive technologies will have little effect on fertiliza-
tion, but can significantly decrease blastocyst production
and clinical pregnancy rates [44]. Yet, our clinical re-
sults over 2 decades have not reflected any impaired
clinical outcomes, other than known differences reported
between NOA and OA paternal sources [17, 45].
Additionally, Wyrobek and others [46] studied age ef-
fects in men and determined that motility and DFI were
inversely correlated, suggesting that specimens with in-
creased motility had decreased DFI. Emiliani and co-
workers [47] further determined that testicular sperm
possessing single stranded (ss)-DNA were more vulner-
able to the denaturing stress of oxidation than double
stranded (ds)-DNA. They further showed that the in-
creased motility of sperm after +72 h IVC correlated
to a reduction in ss-DNA and increase in ds-DNA.
Overall, the accumulated evidence supports our belief
that the use of overtly motile testicular sperm post-
thaw minimizes concerns associated to ROS-mediated
DNA fragmentation that may occur at varying levels
upon IVC and post-cryopreservation.
Our experience has developed an effective management
plan for testicular biopsy/ICSI cycles between urologist/
oocyte retrieval schedules, operating room availability and
the laboratory that does not have to be complicated. A practi-
cal solution rests in adopting a simple and effective testicular
biopsy tissue-processing plan which incorporates pre-freeze
IVC motility enhancement and whole tissue cryopreservation.
We have learned that fresh testicular biopsy samples incubated
at 30 °C can maintain progressive motility for up to 1 week or
more, and their viability can be efficiently cryopreserved as
intact tissue masses. Improvements in future IVC systems,
including the use of microfluidics, will hold promise to en-
hancing motility for weeks, as well as promoting the possible
in vitro maturation of diploid pre-spermatid stages (i.e., sper-
matocytes and spermatogonia) into functional and viable
spermatozoa.
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